PDSB
$2.99
Revenue | $0Mn |
Net Profits | $-10.9Mn |
Net Profit Margins | -Inf% |
Pds Biotechnology Corp’s revenue jumped NaN% since last year same period to $0Mn in the Q4 2023. On a quarterly growth basis, Pds Biotechnology Corp has generated NaN% jump in its revenue since last 3-months.
Pds Biotechnology Corp’s net profit jumped 49.39% since last year same period to $-10.9Mn in the Q4 2023. On a quarterly growth basis, Pds Biotechnology Corp has generated -0.45% fall in its net profits since last 3-months.
Pds Biotechnology Corp’s net profit margin jumped NaN% since last year same period to -Inf% in the Q4 2023. On a quarterly growth basis, Pds Biotechnology Corp has generated NaN% jump in its net profit margins since last 3-months.
EPS Estimate Current Quarter | -0.37 |
EPS Estimate Current Year | -0.37 |
Pds Biotechnology Corp’s earning per share (EPS) estimates for the current quarter stand at -0.37 - a 15.91% jump from last quarter’s estimates.
Pds Biotechnology Corp’s earning per share (EPS) estimates for the current year stand at -0.37.
Earning Per Share (EPS) | -0.35 |
Return on Assets (ROA) | -0.39 |
Return on Equity (ROE) | -1.22 |
Pds Biotechnology Corp’s earning per share (EPS) jumped 47.76% since last year same period to -0.35 in the Q4 2023. This indicates that the Pds Biotechnology Corp has generated 47.76% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Pds Biotechnology Corp’s return on assets (ROA) stands at -0.39.
The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Pds Biotechnology Corp’s return on equity (ROE) stands at -1.22.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2023-12-31 | -0.44 | -0.35 | 20.45% |
2023-08-14 | -0.35 | -0.37 | -5.71% |
2023-05-15 | -0.31 | -0.32 | -3.23% |
2023-11-14 | -0.45 | -0.35 | 22.22% |